Pacific Biosciences of California, Inc.
MX ˙ BMV ˙ US69404D1081
SecurityMX:PACB / Pacific Biosciences of California, Inc.
InstitutionTwo Sigma Investments, Lp
ManagerJohn Overdeck, David Siegel
Latest Disclosed Ownership3,509,613 shares
Latest Disclosed Value $ 4,632,689
Two Sigma Investments, Lp reports 21.98% increase in ownership of PACB / Pacific Biosciences of California, Inc.

On May 15, 2026 - Two Sigma Investments, Lp filed a 13F-HR form disclosing ownership of 3,509,613 shares of Pacific Biosciences of California, Inc. (MX:PACB) valued at $4,632,689 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 2,877,184 shares of Pacific Biosciences of California, Inc.. This represents a change in shares of 21.98% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 3,509,613 632,429 21.98 4,633 -13.90 0.0037
2026-02-17 2025-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 2,877,184 2,475,418 616.13 5,380 946.69 0.0076
2025-11-14 2025-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 401,766 401,766 514 0.0008
2025-08-14 2025-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -542,200 -100.00 0 -100.00
2025-05-15 2025-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 542,200 -571,377 -51.31 640 -68.63 0.0014
2025-02-14 2024-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,113,577 648,407 139.39 2,038 157.85 0.0044
2024-11-14 2024-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 465,170 -370,250 -44.32 791 -30.94 0.0017
2024-08-14 2024-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 835,420 646,728 342.74 1,145 61.81 0.0026
2024-05-15 2024-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 188,692 115,119 156.47 708 -1.94 0.0017
2024-02-14 2023-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 73,573 -289,084 -79.71 722 -76.19 0.0017
2023-11-14 2023-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 362,657 -402,115 -52.58 3,028 -70.23 0.0081
2023-08-14 2023-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 764,772 704,972 1,178.88 10,171 1,369.80 0.0255
2023-05-15 2023-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 59,800 0 0.00 692 41.51 0.0020
2023-02-14 2022-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 59,800 59,800 489 0.0015
2022-11-14 2022-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -4,487,462 -100.00 0 -100.00
2022-08-15 2022-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 4,487,462 1,399,307 45.31 19,835 -29.42 0.0655
2022-05-16 2022-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 3,088,155 2,699,194 693.95 28,102 253.13 0.0829
2022-02-14 2021-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 388,961 -532,651 -57.80 7,958 -66.20 0.0170
2021-11-15 2021-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 921,612 -591,117 -39.08 23,547 -55.49 0.0526
2021-08-16 2021-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,512,729 97,846 6.92 52,900 12.24 0.1200
2021-05-17 2021-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 1,414,883 1,414,883 -6.47 47,130 -10.91 0.1226
2020-11-16 2020-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -28,694 -100.00 0 -100.00
2020-08-14 2020-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 28,694 28,694 99 0.0005
2018-05-15 2018-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -140,298 -100.00 0 -100.00
2018-02-14 2017-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 140,298 140,298 370 0.0012
2016-08-15 2016-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -111,292 -100.00 0 -100.00
2016-05-16 2016-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 111,292 111,292 0.00 946 0.0045
2016-02-16 2015-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 0 0 0.0000
2015-05-15 2015-03-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -63,466 -100.00 0 -100.00
2016-02-09 2014-12-31 13F/A-1 PACIFIC BIOSCIENCES CALIF IN COM 69404D108 63,466 63,466 112.59 498 201.82 0.0029
2015-02-17 2014-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 63,466 498
2014-02-14 2013-12-31 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 0 -29,854 -100.00 0 -100.00
2013-11-14 2013-09-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 29,854 2,954 10.98 165 142.65 0.0011
2013-08-14 2013-06-30 13F PACIFIC BIOSCIENCES CALIF IN COM 69404D108 26,900 26,900 68 0.0005
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.